Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pou2f3
|
ENSMUSG00000032015.9 | POU domain, class 2, transcription factor 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr9_43144474_43144625 | Pou2f3 | 1345 | 0.418068 | -0.53 | 2.7e-05 | Click! |
chr9_43210362_43210716 | Pou2f3 | 170 | 0.937604 | -0.45 | 5.8e-04 | Click! |
chr9_43210921_43211072 | Pou2f3 | 627 | 0.666417 | -0.38 | 4.2e-03 | Click! |
chr9_43150199_43150367 | Pou2f3 | 7079 | 0.184089 | -0.21 | 1.2e-01 | Click! |
chr9_43150414_43150565 | Pou2f3 | 7285 | 0.183279 | -0.15 | 2.7e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_136713076_136713349 | 61.69 |
Snap25 |
synaptosomal-associated protein 25 |
241 |
0.93 |
chr16_4540124_4540287 | 50.80 |
Gm15885 |
predicted gene 15885 |
897 |
0.44 |
chr13_83729249_83729585 | 49.78 |
Gm26803 |
predicted gene, 26803 |
165 |
0.9 |
chr5_109556763_109557843 | 46.60 |
Crlf2 |
cytokine receptor-like factor 2 |
830 |
0.53 |
chr13_20472950_20473157 | 45.82 |
Elmo1 |
engulfment and cell motility 1 |
327 |
0.58 |
chr9_56605184_56605356 | 44.47 |
Gm26868 |
predicted gene, 26868 |
1423 |
0.41 |
chrX_41505462_41505615 | 42.09 |
Gria3 |
glutamate receptor, ionotropic, AMPA3 (alpha 3) |
102798 |
0.07 |
chr13_49706394_49706579 | 41.62 |
Iars |
isoleucine-tRNA synthetase |
71 |
0.95 |
chr10_71100943_71101118 | 41.50 |
Gm15647 |
predicted gene 15647 |
18154 |
0.15 |
chr16_85092305_85093056 | 41.06 |
Gm49227 |
predicted gene, 49227 |
12569 |
0.2 |
chr13_83749525_83749738 | 39.92 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
10768 |
0.12 |
chr3_68202202_68202415 | 39.32 |
Gm10292 |
predicted gene 10292 |
130888 |
0.05 |
chr13_84905442_84905636 | 39.01 |
Gm4059 |
predicted gene 4059 |
68778 |
0.12 |
chr5_27873156_27873523 | 38.13 |
Gm5551 |
predicted gene 5551 |
12890 |
0.15 |
chr5_42523495_42523716 | 37.07 |
Gm7181 |
predicted gene 7181 |
23191 |
0.28 |
chr16_44530838_44531222 | 36.96 |
Mir3081 |
microRNA 3081 |
27099 |
0.17 |
chr8_86438967_86439169 | 36.95 |
Abcc12 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 12 |
95679 |
0.07 |
chr6_8294057_8294761 | 36.87 |
Umad1 |
UMAP1-MVP12 associated (UMA) domain containing 1 |
23943 |
0.14 |
chr5_5135037_5135401 | 36.82 |
Gm43623 |
predicted gene 43623 |
4888 |
0.21 |
chr18_40430221_40430372 | 36.56 |
Gm31019 |
predicted gene, 31019 |
9441 |
0.22 |
chr4_128420200_128420503 | 36.49 |
Csmd2 |
CUB and Sushi multiple domains 2 |
56803 |
0.14 |
chr9_23378706_23379211 | 36.01 |
Bmper |
BMP-binding endothelial regulator |
5026 |
0.36 |
chr11_31847247_31847418 | 35.83 |
Gm12107 |
predicted gene 12107 |
14672 |
0.18 |
chr8_16057731_16057906 | 35.59 |
Csmd1 |
CUB and Sushi multiple domains 1 |
73006 |
0.12 |
chr11_17658313_17658672 | 35.48 |
Gm12016 |
predicted gene 12016 |
19309 |
0.28 |
chrX_58445991_58446352 | 34.73 |
Gm14645 |
predicted gene 14645 |
18096 |
0.26 |
chr7_68858424_68858714 | 34.49 |
Gm34664 |
predicted gene, 34664 |
56029 |
0.13 |
chr8_47284778_47285157 | 34.44 |
Stox2 |
storkhead box 2 |
4395 |
0.28 |
chr10_51153468_51153678 | 34.21 |
Gm26257 |
predicted gene, 26257 |
28726 |
0.22 |
chr14_64352291_64352498 | 33.74 |
Msra |
methionine sulfoxide reductase A |
64554 |
0.12 |
chr8_70118830_70119054 | 33.67 |
Ncan |
neurocan |
1931 |
0.15 |
chr15_54256949_54257119 | 33.27 |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
21450 |
0.2 |
chr5_139892641_139892972 | 32.81 |
Gm42423 |
predicted gene 42423 |
3003 |
0.21 |
chr13_84064376_84064611 | 32.79 |
Gm17750 |
predicted gene, 17750 |
279 |
0.93 |
chr11_14350814_14351136 | 32.43 |
Gm12006 |
predicted gene 12006 |
136638 |
0.05 |
chr14_75540763_75541352 | 32.10 |
Cby2 |
chibby family member 2 |
50892 |
0.13 |
chr4_75213011_75213603 | 31.93 |
Dmac1 |
distal membrane arm assembly complex 1 |
64998 |
0.1 |
chr4_72382561_72382773 | 31.77 |
Gm11235 |
predicted gene 11235 |
159999 |
0.04 |
chr16_94227426_94227633 | 31.60 |
Hlcs |
holocarboxylase synthetase (biotin- [propriony-Coenzyme A-carboxylase (ATP-hydrolysing)] ligase) |
4412 |
0.15 |
chr18_25678184_25678915 | 31.48 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
35221 |
0.19 |
chr1_92737945_92738245 | 31.10 |
Gm29483 |
predicted gene 29483 |
20893 |
0.12 |
chr4_20260916_20261170 | 30.27 |
Gm11872 |
predicted gene 11872 |
82663 |
0.1 |
chr1_168908656_168908844 | 30.25 |
Mir6354 |
microRNA 6354 |
110339 |
0.07 |
chr5_20748236_20748446 | 29.94 |
1110060G06Rik |
RIKEN cDNA 1110060G06 gene |
19947 |
0.17 |
chr11_112869991_112870994 | 29.90 |
4933434M16Rik |
RIKEN cDNA 4933434M16 gene |
45313 |
0.16 |
chr2_65995126_65995501 | 29.83 |
Gm13617 |
predicted gene 13617 |
41243 |
0.15 |
chr5_71976810_71977063 | 29.72 |
Gm15617 |
predicted gene 15617 |
56552 |
0.14 |
chr18_67497794_67498327 | 29.34 |
Spire1 |
spire type actin nucleation factor 1 |
331 |
0.86 |
chr12_78153645_78153987 | 29.01 |
Gm24994 |
predicted gene, 24994 |
11730 |
0.2 |
chr12_112542537_112542889 | 29.00 |
Tmem179 |
transmembrane protein 179 |
25966 |
0.13 |
chr15_84622129_84622386 | 28.78 |
Gm34095 |
predicted gene, 34095 |
45140 |
0.12 |
chr10_29217677_29217828 | 28.72 |
9330159F19Rik |
RIKEN cDNA 9330159F19 gene |
6047 |
0.18 |
chr13_84064676_84065083 | 28.54 |
Gm17750 |
predicted gene, 17750 |
107 |
0.97 |
chr5_120365955_120366154 | 28.49 |
Gm42654 |
predicted gene 42654 |
20086 |
0.15 |
chr13_84906124_84906297 | 28.40 |
Gm4059 |
predicted gene 4059 |
68107 |
0.12 |
chr17_69230455_69230719 | 28.37 |
Epb41l3 |
erythrocyte membrane protein band 4.1 like 3 |
13049 |
0.22 |
chr17_72505215_72505607 | 28.27 |
Gm24736 |
predicted gene, 24736 |
5993 |
0.25 |
chr14_79879709_79880028 | 28.23 |
Gm10845 |
predicted gene 10845 |
10692 |
0.16 |
chr5_140095235_140095604 | 28.19 |
Gm16121 |
predicted gene 16121 |
5780 |
0.17 |
chr3_8509423_8509607 | 28.07 |
Stmn2 |
stathmin-like 2 |
0 |
0.98 |
chr8_32959326_32959711 | 28.02 |
Gm3985 |
predicted gene 3985 |
9492 |
0.28 |
chr8_54954036_54954355 | 28.01 |
Gpm6a |
glycoprotein m6a |
648 |
0.67 |
chr7_131465403_131465590 | 27.77 |
Gm44984 |
predicted gene 44984 |
7371 |
0.11 |
chr18_42450249_42450414 | 27.62 |
Gm16415 |
predicted pseudogene 16415 |
9312 |
0.18 |
chrX_38313231_38313611 | 27.58 |
Atp1b4 |
ATPase, (Na+)/K+ transporting, beta 4 polypeptide |
2763 |
0.23 |
chr1_165934649_165934837 | 27.56 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
157 |
0.94 |
chr7_95725840_95726003 | 27.50 |
Gm5037 |
predicted gene 5037 |
187465 |
0.03 |
chr4_30855461_30855660 | 27.49 |
Gm11920 |
predicted gene 11920 |
153025 |
0.04 |
chr2_130352053_130352242 | 27.40 |
Gm14044 |
predicted gene 14044 |
33182 |
0.07 |
chr4_121231048_121231211 | 27.39 |
Gm12890 |
predicted gene 12890 |
3656 |
0.21 |
chr8_76384066_76384241 | 27.36 |
Gm7990 |
predicted gene 7990 |
11571 |
0.22 |
chr4_82946826_82947007 | 27.35 |
Frem1 |
Fras1 related extracellular matrix protein 1 |
6034 |
0.26 |
chr12_10875269_10875443 | 27.28 |
Pgk1-rs7 |
phosphoglycerate kinase-1, related sequence-7 |
24884 |
0.23 |
chr8_15949900_15950086 | 27.21 |
Csmd1 |
CUB and Sushi multiple domains 1 |
34819 |
0.21 |
chr6_55579639_55579954 | 27.18 |
Gm44352 |
predicted gene, 44352 |
46290 |
0.15 |
chr5_99564792_99564949 | 27.11 |
Gm16228 |
predicted gene 16228 |
46563 |
0.11 |
chr7_122478149_122478324 | 26.91 |
Gm14389 |
predicted gene 14389 |
6184 |
0.17 |
chr12_36666970_36667146 | 26.77 |
Gm7252 |
predicted gene 7252 |
127701 |
0.05 |
chr13_78937424_78937962 | 26.77 |
Gm8345 |
predicted gene 8345 |
17099 |
0.29 |
chr19_41190963_41191114 | 26.64 |
Tll2 |
tolloid-like 2 |
15736 |
0.23 |
chr9_41429810_41429998 | 26.63 |
Gm48739 |
predicted gene, 48739 |
10853 |
0.16 |
chr7_91442779_91443391 | 26.38 |
Gm22080 |
predicted gene, 22080 |
50396 |
0.12 |
chr12_107970719_107971066 | 26.35 |
Bcl11b |
B cell leukemia/lymphoma 11B |
32522 |
0.22 |
chr19_41746384_41746957 | 26.26 |
Slit1 |
slit guidance ligand 1 |
3005 |
0.27 |
chr8_10418993_10419394 | 26.23 |
Myo16 |
myosin XVI |
146621 |
0.04 |
chr19_26508722_26508897 | 26.21 |
Gm50379 |
predicted gene, 50379 |
21943 |
0.16 |
chr4_90437683_90437870 | 25.95 |
Gm12635 |
predicted gene 12635 |
15098 |
0.24 |
chr2_105674521_105675719 | 25.85 |
Pax6 |
paired box 6 |
11 |
0.97 |
chr13_84783122_84783632 | 25.82 |
Gm26913 |
predicted gene, 26913 |
92436 |
0.09 |
chr16_77235959_77236165 | 25.81 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
255 |
0.94 |
chr18_63555730_63556014 | 25.79 |
Gm6789 |
predicted gene 6789 |
10737 |
0.15 |
chr1_67366568_67366878 | 25.77 |
Gm26342 |
predicted gene, 26342 |
109499 |
0.06 |
chr12_51188322_51188499 | 25.73 |
Gm7172 |
predicted gene 7172 |
53708 |
0.14 |
chr15_70029567_70029744 | 25.66 |
Gm19782 |
predicted gene, 19782 |
18032 |
0.25 |
chr6_101199141_101199321 | 25.63 |
Pdzrn3 |
PDZ domain containing RING finger 3 |
31 |
0.92 |
chr16_36817674_36817825 | 25.56 |
Eaf2 |
ELL associated factor 2 |
9044 |
0.11 |
chr14_21252622_21252979 | 25.46 |
Adk |
adenosine kinase |
65325 |
0.13 |
chr5_112825174_112825344 | 25.46 |
1700095B10Rik |
RIKEN cDNA 1700095B10 gene |
31927 |
0.16 |
chr16_62686085_62686411 | 25.43 |
Gm9816 |
predicted pseudogene 9816 |
30789 |
0.18 |
chr8_37880541_37880695 | 25.15 |
Gm16205 |
predicted gene 16205 |
91926 |
0.1 |
chr4_5963296_5963573 | 25.08 |
Gm11797 |
predicted gene 11797 |
106440 |
0.07 |
chr2_34107198_34107369 | 25.07 |
C230014O12Rik |
RIKEN cDNA C230014O12 gene |
446 |
0.84 |
chr12_50538426_50538588 | 25.04 |
Prkd1 |
protein kinase D1 |
110591 |
0.07 |
chr11_40397531_40397721 | 24.99 |
Gm12133 |
predicted gene 12133 |
25728 |
0.19 |
chr1_25892110_25892312 | 24.94 |
Gm9884 |
predicted gene 9884 |
61554 |
0.08 |
chr6_18446901_18447365 | 24.83 |
Gm26233 |
predicted gene, 26233 |
2207 |
0.27 |
chr18_45123336_45123706 | 24.74 |
Gm4839 |
predicted gene 4839 |
23605 |
0.15 |
chr3_127749245_127749655 | 24.71 |
Gm23279 |
predicted gene, 23279 |
17856 |
0.1 |
chr7_64634607_64634806 | 24.71 |
Apba2 |
amyloid beta (A4) precursor protein-binding, family A, member 2 |
325 |
0.93 |
chr8_73142666_73143044 | 24.62 |
Gm22532 |
predicted gene, 22532 |
32403 |
0.19 |
chr10_46718374_46718662 | 24.53 |
Gm19994 |
predicted gene, 19994 |
48374 |
0.16 |
chr14_16201667_16201842 | 24.48 |
Rpl31-ps3 |
ribosomal protein L31, pseudogene 3 |
23269 |
0.13 |
chr14_118226046_118226254 | 24.45 |
Gm4675 |
predicted gene 4675 |
10082 |
0.13 |
chr3_66326335_66326732 | 24.39 |
Veph1 |
ventricular zone expressed PH domain-containing 1 |
29696 |
0.18 |
chr9_61509897_61510259 | 24.36 |
Gm34424 |
predicted gene, 34424 |
355 |
0.89 |
chr1_89750576_89750818 | 24.32 |
Agap1 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
38466 |
0.16 |
chr12_65216407_65216643 | 24.28 |
Gm31063 |
predicted gene, 31063 |
3024 |
0.2 |
chr2_52327521_52327681 | 24.26 |
Neb |
nebulin |
7533 |
0.18 |
chr5_131463531_131463682 | 24.23 |
Auts2 |
autism susceptibility candidate 2 |
3455 |
0.28 |
chr18_65563813_65564173 | 24.12 |
Zfp532 |
zinc finger protein 532 |
15919 |
0.11 |
chr3_40070102_40070729 | 24.11 |
Gm42785 |
predicted gene 42785 |
246838 |
0.02 |
chr12_72265742_72265893 | 24.07 |
Rtn1 |
reticulon 1 |
29093 |
0.19 |
chr3_5755164_5755385 | 24.06 |
Gm8797 |
predicted pseudogene 8797 |
4468 |
0.32 |
chr19_26844786_26845745 | 23.98 |
4931403E22Rik |
RIKEN cDNA 4931403E22 gene |
21358 |
0.18 |
chr14_77377991_77378204 | 23.98 |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
2482 |
0.31 |
chr16_21854964_21855126 | 23.95 |
Gm26744 |
predicted gene, 26744 |
9269 |
0.12 |
chr2_123349731_123349904 | 23.93 |
Gm13988 |
predicted gene 13988 |
75893 |
0.13 |
chr7_61878205_61878373 | 23.90 |
Mir344 |
microRNA 344 |
425 |
0.75 |
chr10_70484632_70484945 | 23.83 |
Gm29783 |
predicted gene, 29783 |
20460 |
0.19 |
chr18_14320236_14320668 | 23.79 |
Gm29992 |
predicted gene, 29992 |
10824 |
0.18 |
chr9_29832991_29833171 | 23.71 |
Ntm |
neurotrimin |
130038 |
0.06 |
chr11_77851092_77851280 | 23.69 |
Myo18a |
myosin XVIIIA |
530 |
0.74 |
chr13_84056961_84057458 | 23.66 |
Gm17750 |
predicted gene, 17750 |
7563 |
0.22 |
chr8_109247972_109248175 | 23.66 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
1793 |
0.47 |
chr4_138517534_138517685 | 23.65 |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
63295 |
0.08 |
chr18_38379687_38380169 | 23.61 |
Gm4949 |
predicted gene 4949 |
19390 |
0.11 |
chr8_62576053_62576229 | 23.60 |
Gm7561 |
predicted gene 7561 |
28310 |
0.17 |
chr7_119088115_119088300 | 23.55 |
Gprc5b |
G protein-coupled receptor, family C, group 5, member B |
92996 |
0.07 |
chr4_87883324_87883491 | 23.53 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
8865 |
0.29 |
chr2_70127698_70127885 | 23.39 |
Myo3b |
myosin IIIB |
31493 |
0.2 |
chr9_20703833_20704274 | 23.37 |
Olfm2 |
olfactomedin 2 |
22884 |
0.12 |
chr1_126469936_126470169 | 23.32 |
Nckap5 |
NCK-associated protein 5 |
21596 |
0.28 |
chr4_97661641_97661961 | 23.27 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
28935 |
0.21 |
chr3_88204711_88205055 | 23.26 |
AI849053 |
expressed sequence AI849053 |
288 |
0.76 |
chr15_92596825_92597188 | 23.25 |
Pdzrn4 |
PDZ domain containing RING finger 4 |
120 |
0.98 |
chr1_21803865_21804016 | 23.25 |
Gm38243 |
predicted gene, 38243 |
36574 |
0.19 |
chr13_59040994_59041159 | 23.21 |
Gm34245 |
predicted gene, 34245 |
37220 |
0.14 |
chr9_36827095_36827287 | 23.21 |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
5327 |
0.16 |
chr4_73163256_73163465 | 23.16 |
Gm25769 |
predicted gene, 25769 |
48703 |
0.17 |
chr2_63963866_63964056 | 23.08 |
Fign |
fidgetin |
134027 |
0.06 |
chr2_57375525_57375823 | 23.03 |
Gm13531 |
predicted gene 13531 |
50035 |
0.15 |
chr6_101685845_101686005 | 22.97 |
Gm32453 |
predicted gene, 32453 |
33691 |
0.2 |
chr11_32087276_32087460 | 22.94 |
Gm12108 |
predicted gene 12108 |
13860 |
0.2 |
chr13_28721766_28721947 | 22.86 |
Mir6368 |
microRNA 6368 |
10983 |
0.26 |
chr18_46213235_46213386 | 22.82 |
Trim36 |
tripartite motif-containing 36 |
703 |
0.66 |
chr13_83734346_83734573 | 22.69 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1893 |
0.22 |
chr14_101352726_101352900 | 22.68 |
Hspd1-ps5 |
heat shock protein 1 (chaperonin), pseudogene 5 |
9269 |
0.26 |
chr14_99749385_99749857 | 22.59 |
Gm22970 |
predicted gene, 22970 |
24187 |
0.19 |
chr18_45008987_45009151 | 22.43 |
Gm31706 |
predicted gene, 31706 |
35793 |
0.15 |
chr15_85458876_85459086 | 22.43 |
7530416G11Rik |
RIKEN cDNA 7530416G11 gene |
44246 |
0.13 |
chr1_132222277_132222448 | 22.43 |
Lemd1 |
LEM domain containing 1 |
3952 |
0.14 |
chr10_120026596_120026787 | 22.38 |
Grip1 |
glutamate receptor interacting protein 1 |
33585 |
0.18 |
chr13_36283759_36283936 | 22.34 |
Gm48766 |
predicted gene, 48766 |
31488 |
0.17 |
chr9_50245051_50245269 | 22.31 |
2310003N18Rik |
RIKEN cDNA 2310003N18 gene |
11978 |
0.19 |
chr12_44403738_44404185 | 22.29 |
Gm48182 |
predicted gene, 48182 |
5829 |
0.21 |
chr3_21672509_21672900 | 22.23 |
Gm17935 |
predicted gene, 17935 |
24317 |
0.19 |
chr3_56962365_56962516 | 22.19 |
Gm22269 |
predicted gene, 22269 |
91710 |
0.09 |
chr11_32158171_32158538 | 22.09 |
Gm12109 |
predicted gene 12109 |
26651 |
0.12 |
chr1_25504415_25504593 | 22.09 |
Gm25294 |
predicted gene, 25294 |
53433 |
0.11 |
chr12_120015329_120015493 | 22.08 |
Gm27236 |
predicted gene 27236 |
14884 |
0.24 |
chr18_78563944_78564243 | 22.08 |
Gm26430 |
predicted gene, 26430 |
30635 |
0.18 |
chr13_78181182_78181614 | 22.06 |
Gm38604 |
predicted gene, 38604 |
1761 |
0.26 |
chr6_115123316_115123739 | 22.04 |
Gm17733 |
predicted gene, 17733 |
11308 |
0.13 |
chr5_39416868_39417054 | 22.04 |
Gm5291 |
predicted gene 5291 |
14716 |
0.17 |
chr17_48512615_48513028 | 22.02 |
Gm49896 |
predicted gene, 49896 |
43912 |
0.11 |
chr2_78160222_78160433 | 22.01 |
Gm14461 |
predicted gene 14461 |
77220 |
0.11 |
chr15_32172723_32172933 | 21.99 |
Tas2r119 |
taste receptor, type 2, member 119 |
4461 |
0.24 |
chr10_112203584_112203748 | 21.98 |
Gm47419 |
predicted gene, 47419 |
27475 |
0.13 |
chr7_40392207_40392501 | 21.90 |
Gm28807 |
predicted gene 28807 |
76886 |
0.1 |
chr12_108395688_108396506 | 21.88 |
Eml1 |
echinoderm microtubule associated protein like 1 |
14445 |
0.17 |
chr2_144127773_144127970 | 21.86 |
Gm11687 |
predicted gene 11687 |
15502 |
0.16 |
chr3_105568935_105569110 | 21.83 |
Gm43847 |
predicted gene 43847 |
66115 |
0.1 |
chr14_24644159_24644310 | 21.76 |
4930428N03Rik |
RIKEN cDNA 4930428N03 gene |
22075 |
0.19 |
chr17_70633998_70634208 | 21.75 |
Dlgap1 |
DLG associated protein 1 |
72551 |
0.1 |
chr1_25698811_25699016 | 21.71 |
Gm37628 |
predicted gene, 37628 |
7412 |
0.13 |
chr16_24509582_24509735 | 21.61 |
Morf4l1-ps1 |
mortality factor 4 like 1, pseudogene 1 |
19736 |
0.22 |
chr3_107114477_107114841 | 21.59 |
Kcna2 |
potassium voltage-gated channel, shaker-related subfamily, member 2 |
11977 |
0.14 |
chr9_53916331_53916587 | 21.46 |
Elmod1 |
ELMO/CED-12 domain containing 1 |
10567 |
0.19 |
chr10_109683991_109684368 | 21.45 |
3110043J17Rik |
RIKEN cDNA 3110043J17 gene |
35400 |
0.19 |
chr7_118992569_118993054 | 21.41 |
Gprc5b |
G protein-coupled receptor, family C, group 5, member B |
2400 |
0.3 |
chr6_39903930_39904296 | 21.40 |
Tmem178b |
transmembrane protein 178B |
31042 |
0.14 |
chr13_84062212_84062522 | 21.37 |
Gm17750 |
predicted gene, 17750 |
2405 |
0.33 |
chr10_19396813_19397100 | 21.37 |
Olig3 |
oligodendrocyte transcription factor 3 |
40423 |
0.16 |
chr3_146318754_146318962 | 21.32 |
Gm43334 |
predicted gene 43334 |
5562 |
0.2 |
chr7_77928555_77928706 | 21.32 |
Gm23239 |
predicted gene, 23239 |
18310 |
0.28 |
chr14_64588229_64588406 | 21.32 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
217 |
0.91 |
chr3_45385015_45385410 | 21.29 |
Pcdh10 |
protocadherin 10 |
2579 |
0.24 |
chr2_158588589_158588756 | 21.16 |
Gm14204 |
predicted gene 14204 |
21918 |
0.11 |
chr1_53740102_53740664 | 21.14 |
Stk17b |
serine/threonine kinase 17b (apoptosis-inducing) |
22310 |
0.18 |
chr4_54021441_54021626 | 21.13 |
Gm24177 |
predicted gene, 24177 |
17476 |
0.24 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.5 | 43.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
11.5 | 34.6 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
10.1 | 40.6 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
9.6 | 38.6 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
9.5 | 9.5 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
8.0 | 23.9 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
7.6 | 22.8 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
7.1 | 21.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
6.5 | 19.6 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
5.9 | 41.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
5.9 | 17.6 | GO:0072235 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
5.7 | 11.4 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
5.6 | 94.5 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
5.6 | 16.7 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
5.5 | 38.2 | GO:0016198 | axon choice point recognition(GO:0016198) |
5.4 | 16.2 | GO:0046684 | response to pyrethroid(GO:0046684) |
5.4 | 10.7 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
5.3 | 26.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
4.9 | 14.8 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
4.9 | 34.0 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
4.8 | 14.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
4.7 | 14.0 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
4.5 | 18.1 | GO:0061743 | motor learning(GO:0061743) |
4.5 | 22.4 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
4.5 | 17.8 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
4.4 | 30.8 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
4.3 | 34.5 | GO:0071420 | cellular response to histamine(GO:0071420) |
4.1 | 20.6 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
4.1 | 12.2 | GO:0021564 | vagus nerve development(GO:0021564) |
4.1 | 8.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
4.0 | 12.0 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
4.0 | 15.8 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
3.9 | 31.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
3.9 | 11.6 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
3.8 | 15.4 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
3.6 | 10.7 | GO:0007412 | axon target recognition(GO:0007412) |
3.6 | 17.9 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
3.6 | 14.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
3.5 | 6.9 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
3.4 | 17.1 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
3.4 | 16.9 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
3.3 | 9.9 | GO:1990034 | calcium ion export from cell(GO:1990034) |
3.3 | 13.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
3.2 | 3.2 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
3.2 | 22.5 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
3.2 | 12.7 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
3.2 | 15.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
3.1 | 15.6 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
3.1 | 9.3 | GO:0060486 | Clara cell differentiation(GO:0060486) |
3.1 | 15.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
3.0 | 3.0 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
3.0 | 9.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
3.0 | 6.0 | GO:0031223 | auditory behavior(GO:0031223) |
2.8 | 5.6 | GO:0061642 | chemoattraction of axon(GO:0061642) |
2.8 | 11.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
2.8 | 8.3 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
2.8 | 22.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
2.7 | 8.2 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
2.7 | 2.7 | GO:0021586 | pons maturation(GO:0021586) |
2.7 | 13.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
2.7 | 13.3 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
2.7 | 2.7 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
2.6 | 13.2 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
2.6 | 13.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
2.6 | 13.0 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
2.6 | 7.7 | GO:0001927 | exocyst assembly(GO:0001927) |
2.6 | 10.2 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
2.5 | 7.6 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
2.5 | 10.1 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
2.5 | 12.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
2.5 | 24.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
2.4 | 9.7 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
2.4 | 7.2 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
2.4 | 7.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
2.4 | 14.2 | GO:0022605 | oogenesis stage(GO:0022605) |
2.4 | 7.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
2.4 | 9.4 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
2.4 | 4.7 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
2.3 | 7.0 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
2.3 | 7.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
2.3 | 9.3 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
2.3 | 20.5 | GO:0045176 | apical protein localization(GO:0045176) |
2.2 | 6.6 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
2.2 | 17.5 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
2.2 | 4.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
2.2 | 37.0 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
2.2 | 6.5 | GO:0021557 | oculomotor nerve development(GO:0021557) |
2.2 | 8.7 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
2.2 | 6.5 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
2.2 | 6.5 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
2.1 | 8.6 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
2.1 | 8.4 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
2.1 | 6.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
2.0 | 8.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
2.0 | 6.1 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
2.0 | 6.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
2.0 | 9.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
2.0 | 5.9 | GO:0023041 | neuronal signal transduction(GO:0023041) |
2.0 | 19.6 | GO:0060134 | prepulse inhibition(GO:0060134) |
1.9 | 3.8 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
1.9 | 5.7 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.9 | 9.4 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.9 | 22.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.8 | 3.7 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
1.8 | 14.6 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
1.8 | 5.5 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.8 | 7.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.8 | 5.4 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
1.8 | 3.6 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.8 | 5.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.8 | 8.9 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
1.7 | 7.0 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
1.7 | 5.2 | GO:0015747 | urate transport(GO:0015747) |
1.7 | 1.7 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
1.7 | 5.0 | GO:0060005 | vestibular reflex(GO:0060005) |
1.7 | 19.9 | GO:0001964 | startle response(GO:0001964) |
1.6 | 3.3 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
1.6 | 11.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
1.6 | 6.4 | GO:0030091 | protein repair(GO:0030091) |
1.6 | 6.3 | GO:0071047 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
1.6 | 3.2 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
1.6 | 9.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.6 | 3.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.6 | 130.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.5 | 15.4 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
1.5 | 4.6 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
1.5 | 3.0 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.5 | 4.5 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
1.5 | 3.0 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
1.5 | 4.5 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.5 | 6.0 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
1.5 | 3.0 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
1.5 | 5.9 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
1.5 | 5.9 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
1.5 | 7.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.5 | 13.2 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
1.5 | 4.4 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.4 | 7.2 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
1.4 | 4.3 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
1.4 | 4.3 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
1.4 | 9.9 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
1.4 | 2.8 | GO:0046959 | habituation(GO:0046959) |
1.4 | 2.8 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
1.4 | 2.8 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.4 | 2.8 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.4 | 7.0 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
1.4 | 9.7 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
1.4 | 4.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
1.4 | 2.7 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
1.4 | 6.9 | GO:0019532 | oxalate transport(GO:0019532) |
1.4 | 4.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.4 | 4.1 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.4 | 4.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
1.3 | 5.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.3 | 2.7 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
1.3 | 14.7 | GO:0035418 | protein localization to synapse(GO:0035418) |
1.3 | 2.7 | GO:0006562 | proline catabolic process(GO:0006562) |
1.3 | 4.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
1.3 | 7.9 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
1.3 | 11.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
1.3 | 5.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
1.3 | 3.9 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
1.3 | 5.2 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
1.3 | 3.9 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
1.3 | 2.6 | GO:0019230 | proprioception(GO:0019230) |
1.3 | 3.8 | GO:0030070 | insulin processing(GO:0030070) |
1.3 | 3.8 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.3 | 3.8 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
1.3 | 5.0 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
1.2 | 3.7 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
1.2 | 6.2 | GO:0090383 | phagosome acidification(GO:0090383) |
1.2 | 12.3 | GO:0032570 | response to progesterone(GO:0032570) |
1.2 | 11.0 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
1.2 | 3.6 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.2 | 35.0 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
1.2 | 2.4 | GO:0046098 | guanine metabolic process(GO:0046098) |
1.2 | 6.0 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
1.2 | 2.4 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.2 | 2.4 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
1.2 | 3.6 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.2 | 3.5 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.2 | 36.3 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
1.2 | 4.7 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
1.2 | 2.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.1 | 3.4 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
1.1 | 7.9 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.1 | 1.1 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
1.1 | 3.3 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.1 | 5.6 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.1 | 1.1 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
1.1 | 3.3 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
1.1 | 18.8 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
1.1 | 2.2 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
1.1 | 5.5 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
1.1 | 2.2 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.1 | 9.8 | GO:0021542 | dentate gyrus development(GO:0021542) |
1.1 | 2.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.1 | 3.2 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.1 | 9.7 | GO:0001975 | response to amphetamine(GO:0001975) |
1.1 | 1.1 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
1.1 | 5.3 | GO:0060179 | male mating behavior(GO:0060179) |
1.0 | 1.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.0 | 2.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.0 | 1.0 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
1.0 | 4.1 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
1.0 | 3.1 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.0 | 3.0 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
1.0 | 3.0 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
1.0 | 3.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
1.0 | 3.0 | GO:0021772 | olfactory bulb development(GO:0021772) |
1.0 | 1.0 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
1.0 | 11.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
1.0 | 3.0 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.0 | 1.0 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.0 | 2.9 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
1.0 | 2.9 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
1.0 | 4.9 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
1.0 | 4.9 | GO:0008038 | neuron recognition(GO:0008038) |
1.0 | 1.9 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.0 | 3.8 | GO:0022038 | corpus callosum development(GO:0022038) |
1.0 | 6.7 | GO:0006108 | malate metabolic process(GO:0006108) |
0.9 | 1.9 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.9 | 4.7 | GO:0050957 | equilibrioception(GO:0050957) |
0.9 | 7.5 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.9 | 20.7 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.9 | 1.9 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.9 | 5.6 | GO:0060539 | diaphragm development(GO:0060539) |
0.9 | 3.7 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.9 | 4.6 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.9 | 0.9 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.9 | 2.8 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.9 | 6.4 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.9 | 4.6 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.9 | 7.2 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.9 | 10.8 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.9 | 3.6 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.9 | 2.7 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.9 | 4.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.9 | 3.6 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.9 | 2.7 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.9 | 1.8 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.9 | 4.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.9 | 3.5 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.9 | 0.9 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.9 | 2.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.9 | 6.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.9 | 2.6 | GO:1904220 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.9 | 4.4 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.9 | 2.6 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.9 | 0.9 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
0.9 | 2.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.9 | 2.6 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.9 | 0.9 | GO:2000301 | negative regulation of synaptic vesicle transport(GO:1902804) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.9 | 2.6 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.9 | 1.7 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.8 | 7.6 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.8 | 0.8 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.8 | 7.6 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.8 | 2.5 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.8 | 2.5 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.8 | 4.2 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.8 | 2.5 | GO:0060897 | neural plate regionalization(GO:0060897) |
0.8 | 1.7 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.8 | 34.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.8 | 2.5 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.8 | 8.3 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.8 | 0.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.8 | 2.5 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.8 | 4.1 | GO:0071625 | vocalization behavior(GO:0071625) |
0.8 | 2.4 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.8 | 2.4 | GO:0070268 | cornification(GO:0070268) |
0.8 | 1.6 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.8 | 3.2 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.8 | 2.4 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.8 | 4.0 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.8 | 0.8 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.8 | 6.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.8 | 3.9 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.8 | 3.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.8 | 4.7 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.8 | 0.8 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.8 | 2.3 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.8 | 7.7 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.8 | 1.5 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.8 | 2.3 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.8 | 6.8 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.8 | 0.8 | GO:1904023 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.8 | 0.8 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.8 | 3.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.8 | 1.5 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.8 | 2.3 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
0.7 | 6.7 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.7 | 2.2 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.7 | 1.5 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
0.7 | 1.5 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.7 | 0.7 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.7 | 8.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.7 | 5.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.7 | 2.2 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.7 | 0.7 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.7 | 2.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.7 | 1.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.7 | 1.4 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.7 | 1.4 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.7 | 2.9 | GO:0046909 | intermembrane transport(GO:0046909) |
0.7 | 5.7 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.7 | 9.9 | GO:0007616 | long-term memory(GO:0007616) |
0.7 | 1.4 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.7 | 0.7 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.7 | 0.7 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
0.7 | 0.7 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.7 | 6.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.7 | 2.8 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.7 | 2.1 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.7 | 4.8 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.7 | 1.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.7 | 2.0 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.7 | 2.0 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.7 | 2.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.7 | 2.0 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.7 | 4.0 | GO:0015074 | DNA integration(GO:0015074) |
0.7 | 1.3 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.7 | 0.7 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.7 | 2.6 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.7 | 2.0 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.7 | 0.7 | GO:0072193 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.7 | 2.0 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.7 | 0.7 | GO:2000412 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.7 | 2.6 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.6 | 5.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.6 | 4.5 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.6 | 2.6 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.6 | 2.6 | GO:0042891 | antibiotic transport(GO:0042891) |
0.6 | 1.3 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.6 | 1.9 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.6 | 4.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.6 | 2.5 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.6 | 2.5 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.6 | 1.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.6 | 1.8 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.6 | 4.3 | GO:0035510 | DNA dealkylation(GO:0035510) DNA demethylation(GO:0080111) |
0.6 | 1.8 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.6 | 16.9 | GO:0007340 | acrosome reaction(GO:0007340) |
0.6 | 0.6 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.6 | 3.0 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.6 | 2.3 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.6 | 1.8 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.6 | 9.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.6 | 14.6 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.6 | 1.2 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.6 | 1.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.6 | 2.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.6 | 2.3 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.6 | 0.6 | GO:0032095 | regulation of response to food(GO:0032095) |
0.6 | 1.1 | GO:0060594 | mammary gland specification(GO:0060594) |
0.6 | 0.6 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.6 | 2.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.6 | 0.6 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.6 | 3.9 | GO:0071435 | potassium ion export(GO:0071435) |
0.6 | 2.8 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.5 | 2.2 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.5 | 1.6 | GO:2000665 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.5 | 0.5 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.5 | 0.5 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.5 | 1.6 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.5 | 1.6 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.5 | 1.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.5 | 0.5 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.5 | 21.8 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.5 | 2.1 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.5 | 2.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.5 | 1.6 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.5 | 5.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.5 | 1.6 | GO:0042048 | olfactory behavior(GO:0042048) |
0.5 | 1.6 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.5 | 1.5 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.5 | 1.5 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.5 | 1.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.5 | 1.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.5 | 1.5 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.5 | 2.0 | GO:0035627 | ceramide transport(GO:0035627) |
0.5 | 1.5 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.5 | 1.0 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.5 | 0.5 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.5 | 3.0 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.5 | 0.5 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.5 | 1.5 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.5 | 12.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.5 | 3.5 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.5 | 1.0 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.5 | 12.7 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.5 | 8.3 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.5 | 1.5 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.5 | 1.4 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.5 | 1.4 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.5 | 1.4 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.5 | 6.2 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.5 | 0.5 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.5 | 3.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.5 | 1.9 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.5 | 3.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.5 | 0.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.5 | 3.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.5 | 1.4 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.5 | 0.5 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.5 | 0.5 | GO:1902669 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.5 | 1.4 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
0.5 | 0.9 | GO:0060166 | olfactory pit development(GO:0060166) |
0.4 | 2.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.4 | 0.4 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.4 | 0.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.4 | 1.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.4 | 0.9 | GO:0006868 | glutamine transport(GO:0006868) |
0.4 | 0.4 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.4 | 3.1 | GO:2000727 | positive regulation of cardiac muscle cell differentiation(GO:2000727) |
0.4 | 0.4 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.4 | 1.3 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.4 | 3.9 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.4 | 7.8 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.4 | 0.9 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.4 | 3.9 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.4 | 1.7 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.4 | 1.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.4 | 4.2 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.4 | 0.8 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.4 | 2.5 | GO:0006983 | ER overload response(GO:0006983) |
0.4 | 1.3 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.4 | 0.4 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.4 | 0.4 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
0.4 | 0.4 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.4 | 1.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.4 | 4.5 | GO:0021879 | forebrain neuron differentiation(GO:0021879) |
0.4 | 2.5 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.4 | 0.4 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.4 | 0.8 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.4 | 0.4 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.4 | 0.4 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.4 | 0.4 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.4 | 1.2 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.4 | 1.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.4 | 0.4 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.4 | 2.0 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.4 | 2.4 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.4 | 1.6 | GO:0030432 | peristalsis(GO:0030432) |
0.4 | 0.4 | GO:0061439 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
0.4 | 3.2 | GO:0046541 | saliva secretion(GO:0046541) |
0.4 | 1.2 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.4 | 5.1 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.4 | 5.5 | GO:0032098 | regulation of appetite(GO:0032098) |
0.4 | 1.6 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.4 | 1.2 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.4 | 0.8 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.4 | 1.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.4 | 0.8 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.4 | 1.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 5.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.4 | 3.5 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.4 | 0.8 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
0.4 | 1.9 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.4 | 1.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.4 | 0.8 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.4 | 1.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.4 | 0.4 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.4 | 4.8 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.4 | 1.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.4 | 0.4 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.4 | 1.1 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.4 | 1.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.4 | 3.7 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.4 | 0.4 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.4 | 4.3 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.4 | 0.4 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.4 | 1.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.4 | 3.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.4 | 1.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.4 | 0.7 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.4 | 0.7 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.4 | 5.7 | GO:0000154 | rRNA modification(GO:0000154) |
0.4 | 1.4 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.3 | 1.7 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.3 | 32.8 | GO:0007626 | locomotory behavior(GO:0007626) |
0.3 | 0.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.3 | 16.8 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.3 | 5.8 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 1.0 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.3 | 0.7 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 1.7 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.3 | 2.4 | GO:0060736 | prostate gland growth(GO:0060736) |
0.3 | 4.0 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.3 | 0.3 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.3 | 0.7 | GO:0072017 | distal tubule development(GO:0072017) |
0.3 | 1.3 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.3 | 1.0 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 1.0 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.3 | 5.1 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.3 | 0.9 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.3 | 1.6 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.3 | 0.9 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.3 | 0.3 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.3 | 1.6 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.3 | 1.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 0.6 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 0.3 | GO:0038089 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.3 | 0.6 | GO:0051383 | kinetochore organization(GO:0051383) |
0.3 | 0.6 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.3 | 0.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.3 | 0.6 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.3 | 2.1 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.3 | 0.6 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.3 | 0.6 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.3 | 4.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.3 | 3.8 | GO:1902667 | regulation of axon guidance(GO:1902667) |
0.3 | 1.7 | GO:0090382 | phagosome maturation(GO:0090382) |
0.3 | 1.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.3 | 0.6 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.3 | 2.0 | GO:0032674 | regulation of interleukin-5 production(GO:0032674) |
0.3 | 0.9 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.3 | 0.6 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 1.4 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.3 | 0.3 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.3 | 0.3 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.3 | 0.5 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.3 | 3.3 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.3 | 0.3 | GO:0007567 | parturition(GO:0007567) |
0.3 | 0.5 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 0.5 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.3 | 1.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 7.3 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.3 | 1.8 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.3 | 0.8 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.3 | 1.0 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.3 | 3.1 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.3 | 0.8 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.3 | 2.3 | GO:0031297 | replication fork processing(GO:0031297) |
0.3 | 1.0 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.3 | 6.6 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.3 | 0.3 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.3 | 0.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.3 | 1.0 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.3 | 1.0 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 1.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.2 | 0.5 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.2 | 1.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 0.5 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.2 | 0.2 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.2 | 0.5 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.2 | 0.7 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.2 | 0.7 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.2 | 1.4 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 1.6 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.2 | 0.9 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 0.5 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.2 | 0.7 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.2 | 1.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 0.9 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.2 | 0.7 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.2 | 2.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 1.8 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.2 | 0.9 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 0.2 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.2 | 1.3 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.2 | 2.2 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.2 | 0.4 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.2 | 0.9 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.2 | 0.4 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 0.4 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 0.2 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.2 | 0.8 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.2 | 3.5 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 1.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 0.6 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.2 | 1.0 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.2 | 0.6 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.2 | 1.0 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.2 | 0.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 1.0 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.2 | 0.2 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.2 | 0.2 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.2 | 0.4 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.2 | 0.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 0.6 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 0.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.2 | 0.6 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 2.5 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.2 | 1.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.2 | 0.8 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 0.4 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.2 | 0.4 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.2 | 0.2 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.2 | 0.4 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 0.2 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.2 | 0.7 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.2 | 0.7 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 0.4 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.2 | 0.4 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.2 | 0.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 0.5 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.2 | 0.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.2 | 1.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.2 | 0.2 | GO:0006848 | pyruvate transport(GO:0006848) |
0.2 | 4.6 | GO:0006284 | base-excision repair(GO:0006284) |
0.2 | 2.7 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.2 | 2.0 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.2 | 0.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.2 | 0.2 | GO:0061196 | fungiform papilla development(GO:0061196) |
0.2 | 0.2 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.2 | 1.1 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.2 | 0.2 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.2 | 0.5 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 0.6 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.2 | 0.6 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.2 | 0.5 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.6 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 0.2 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.2 | 0.5 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 1.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 1.1 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.4 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 0.6 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.3 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 0.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.6 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.1 | 0.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.1 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 0.4 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.1 | 0.3 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.4 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.4 | GO:0030035 | microspike assembly(GO:0030035) |
0.1 | 0.8 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 1.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.4 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.1 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.1 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.1 | 0.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 0.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.3 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.6 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.1 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.1 | 1.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 5.3 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 2.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.7 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.1 | 0.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.1 | 0.7 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 0.2 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.2 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.2 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.1 | 1.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.8 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.7 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.7 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.3 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 1.0 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.5 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.7 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 0.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.9 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.1 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.1 | 0.3 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.2 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.1 | GO:0086026 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.1 | 3.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.3 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 0.3 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.5 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.1 | 0.3 | GO:0046218 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.1 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.4 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.5 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.1 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.1 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 1.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.2 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.2 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.1 | 0.1 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 0.2 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 0.2 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 0.7 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.2 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.1 | GO:0038001 | paracrine signaling(GO:0038001) |
0.1 | 0.5 | GO:0048665 | neuron fate specification(GO:0048665) |
0.1 | 0.1 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.1 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.6 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.1 | 0.2 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
0.1 | 0.1 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.1 | 0.1 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.1 | 0.1 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.1 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.1 | 0.1 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.1 | 0.6 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.1 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 1.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.2 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.1 | 0.1 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.1 | 0.1 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.1 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.1 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.1 | 0.1 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.1 | 0.3 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.6 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.2 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 0.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.2 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.1 | 0.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.1 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.1 | 0.1 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.1 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.1 | 0.1 | GO:0090135 | actin filament branching(GO:0090135) |
0.0 | 0.0 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.0 | 0.3 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.0 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.0 | 0.1 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.0 | 0.3 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.0 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.0 | 0.1 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.0 | 0.2 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.0 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.0 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.1 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.0 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:0006596 | polyamine biosynthetic process(GO:0006596) |
0.0 | 0.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.2 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.0 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.0 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 0.2 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 0.1 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.0 | 0.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.0 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.0 | 0.2 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.8 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 0.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.0 | 0.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.6 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.0 | 0.0 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.0 | 0.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.0 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.0 | 0.0 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.0 | 0.0 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.0 | 0.0 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.0 | 0.0 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.0 | 0.2 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.2 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 0.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.0 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.0 | 0.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.1 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.0 | 0.0 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.1 | GO:0007135 | meiosis II(GO:0007135) |
0.0 | 0.0 | GO:0015817 | histidine transport(GO:0015817) |
0.0 | 0.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.0 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.3 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.0 | 0.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.0 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.2 | 68.8 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
5.6 | 50.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
5.6 | 55.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
3.5 | 63.5 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
3.5 | 14.1 | GO:0033010 | paranodal junction(GO:0033010) |
3.4 | 10.2 | GO:0072534 | perineuronal net(GO:0072534) |
3.3 | 6.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
3.2 | 12.9 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
2.9 | 20.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
2.6 | 7.9 | GO:1990812 | growth cone filopodium(GO:1990812) |
2.6 | 13.0 | GO:0000235 | astral microtubule(GO:0000235) |
2.6 | 13.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
2.5 | 9.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
2.3 | 14.0 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
2.2 | 8.8 | GO:0030478 | actin cap(GO:0030478) |
2.1 | 12.7 | GO:0016012 | sarcoglycan complex(GO:0016012) |
2.1 | 48.5 | GO:0044295 | axonal growth cone(GO:0044295) |
2.1 | 20.7 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
2.0 | 7.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
2.0 | 9.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.9 | 19.4 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
1.9 | 11.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.8 | 20.1 | GO:0043194 | axon initial segment(GO:0043194) |
1.8 | 12.8 | GO:0044292 | dendrite terminus(GO:0044292) |
1.8 | 7.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
1.8 | 17.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.7 | 29.7 | GO:0030673 | axolemma(GO:0030673) |
1.7 | 5.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.7 | 13.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.7 | 8.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.7 | 5.1 | GO:0033269 | internode region of axon(GO:0033269) |
1.6 | 4.8 | GO:0097441 | basilar dendrite(GO:0097441) |
1.6 | 6.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
1.6 | 3.1 | GO:0097449 | astrocyte projection(GO:0097449) |
1.6 | 6.3 | GO:0045293 | mRNA editing complex(GO:0045293) |
1.6 | 4.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.5 | 11.7 | GO:0043083 | synaptic cleft(GO:0043083) |
1.4 | 4.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.4 | 8.5 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
1.4 | 4.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.4 | 5.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.3 | 4.0 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.3 | 4.0 | GO:0043293 | apoptosome(GO:0043293) |
1.3 | 3.9 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.3 | 57.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.3 | 6.3 | GO:0071547 | piP-body(GO:0071547) |
1.2 | 10.0 | GO:0071437 | invadopodium(GO:0071437) |
1.2 | 7.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.2 | 8.4 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
1.2 | 1.2 | GO:0044298 | cell body membrane(GO:0044298) |
1.1 | 11.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.1 | 10.0 | GO:0031512 | motile primary cilium(GO:0031512) |
1.1 | 13.1 | GO:0032426 | stereocilium tip(GO:0032426) |
1.1 | 3.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.0 | 3.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
1.0 | 2.0 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.0 | 4.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.0 | 4.9 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.9 | 15.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.9 | 1.9 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.9 | 5.7 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.9 | 2.8 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.9 | 2.8 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.9 | 2.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.9 | 6.5 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.9 | 1.8 | GO:0032280 | symmetric synapse(GO:0032280) |
0.9 | 1.8 | GO:1990357 | terminal web(GO:1990357) |
0.8 | 22.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.8 | 23.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.8 | 6.7 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.8 | 2.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.8 | 128.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.8 | 4.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.8 | 2.4 | GO:0097427 | microtubule bundle(GO:0097427) |
0.8 | 2.3 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.8 | 10.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.8 | 13.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.8 | 73.2 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.7 | 3.6 | GO:0097433 | dense body(GO:0097433) |
0.7 | 1.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.7 | 6.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.7 | 7.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.7 | 33.3 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.7 | 7.2 | GO:0031045 | dense core granule(GO:0031045) |
0.6 | 3.9 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.6 | 1.9 | GO:0000802 | transverse filament(GO:0000802) |
0.6 | 1.8 | GO:0005955 | calcineurin complex(GO:0005955) |
0.6 | 4.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.6 | 3.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.6 | 1.8 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.6 | 2.3 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.6 | 4.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.6 | 16.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.6 | 2.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.6 | 6.6 | GO:0071564 | npBAF complex(GO:0071564) |
0.6 | 6.1 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.5 | 0.5 | GO:0031523 | Myb complex(GO:0031523) |
0.5 | 2.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.5 | 0.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.5 | 8.7 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.5 | 1.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.5 | 9.1 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.5 | 1.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.5 | 1.5 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.5 | 4.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.5 | 0.5 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.5 | 1.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.5 | 7.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.5 | 10.0 | GO:0034451 | centriolar satellite(GO:0034451) |
0.5 | 2.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.5 | 1.4 | GO:0042827 | platelet dense granule(GO:0042827) |
0.5 | 5.0 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.5 | 3.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.5 | 8.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.5 | 1.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.5 | 4.5 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.5 | 1.8 | GO:0070545 | PeBoW complex(GO:0070545) |
0.4 | 4.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.4 | 36.3 | GO:0030426 | growth cone(GO:0030426) |
0.4 | 1.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 1.3 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.4 | 3.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.4 | 3.6 | GO:0030897 | HOPS complex(GO:0030897) |
0.4 | 0.8 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.4 | 5.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.4 | 3.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.4 | 3.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.4 | 4.1 | GO:0042555 | MCM complex(GO:0042555) |
0.4 | 3.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.4 | 1.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.4 | 22.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.4 | 1.1 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.4 | 1.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.3 | 2.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 4.9 | GO:0043205 | fibril(GO:0043205) |
0.3 | 4.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.3 | 0.7 | GO:0005767 | secondary lysosome(GO:0005767) |
0.3 | 2.0 | GO:0001739 | sex chromatin(GO:0001739) |
0.3 | 1.0 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.3 | 1.9 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.3 | 7.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.3 | 0.3 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.3 | 1.3 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.3 | 1.5 | GO:0001940 | male pronucleus(GO:0001940) |
0.3 | 0.3 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.3 | 2.4 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.3 | 1.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.3 | 2.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 1.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.3 | 0.5 | GO:0032590 | dendrite membrane(GO:0032590) |
0.3 | 2.1 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.3 | 2.4 | GO:0043034 | costamere(GO:0043034) |
0.3 | 0.5 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 1.3 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 1.6 | GO:0071986 | Ragulator complex(GO:0071986) |
0.3 | 0.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 6.1 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.3 | 0.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 1.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 0.7 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 1.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 1.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 3.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 50.8 | GO:0030424 | axon(GO:0030424) |
0.2 | 0.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.2 | 0.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 3.0 | GO:0031011 | Ino80 complex(GO:0031011) |
0.2 | 0.5 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 1.8 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 2.2 | GO:0005687 | U4 snRNP(GO:0005687) |
0.2 | 0.9 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 3.1 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.2 | 2.9 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 2.2 | GO:0001741 | XY body(GO:0001741) |
0.2 | 0.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 0.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 0.4 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 4.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 0.6 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 4.8 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 0.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 2.9 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.2 | 0.9 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 0.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 8.1 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 0.2 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 1.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 0.8 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.6 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 0.3 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 35.3 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.1 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.7 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 1.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.8 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.1 | GO:0034705 | potassium channel complex(GO:0034705) |
0.1 | 2.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.3 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.9 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.5 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 1.3 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 7.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 1.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.4 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.8 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.3 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.6 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.3 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.1 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.3 | 24.9 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
7.3 | 21.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
7.0 | 20.9 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
6.8 | 20.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
6.2 | 30.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
5.9 | 41.0 | GO:0003680 | AT DNA binding(GO:0003680) |
5.7 | 17.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
5.7 | 28.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
4.4 | 13.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
4.3 | 17.0 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
4.1 | 20.6 | GO:0070883 | pre-miRNA binding(GO:0070883) |
4.0 | 16.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
3.9 | 77.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
3.7 | 22.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
3.4 | 63.9 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
3.3 | 13.2 | GO:0097001 | ceramide binding(GO:0097001) |
3.3 | 13.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
3.2 | 9.7 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
3.2 | 12.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
3.0 | 12.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
2.8 | 25.1 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
2.7 | 8.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
2.7 | 8.0 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
2.5 | 29.5 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
2.5 | 7.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
2.4 | 12.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
2.3 | 20.6 | GO:0038191 | neuropilin binding(GO:0038191) |
1.9 | 5.7 | GO:0016917 | GABA receptor activity(GO:0016917) |
1.9 | 5.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.9 | 5.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.8 | 7.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.8 | 9.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.8 | 5.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.8 | 8.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.7 | 10.4 | GO:0048495 | Roundabout binding(GO:0048495) |
1.7 | 8.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.7 | 3.4 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
1.7 | 5.0 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
1.7 | 8.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
1.6 | 6.6 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
1.6 | 12.9 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
1.6 | 6.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.6 | 3.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.6 | 6.2 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
1.5 | 6.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.5 | 3.0 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
1.5 | 4.5 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.5 | 9.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
1.5 | 4.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.5 | 7.4 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.4 | 4.3 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
1.4 | 8.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.4 | 5.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.4 | 4.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.4 | 5.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.3 | 5.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.3 | 5.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
1.3 | 6.5 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.3 | 41.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.3 | 6.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
1.3 | 8.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.3 | 7.6 | GO:0030955 | potassium ion binding(GO:0030955) |
1.3 | 3.8 | GO:0000403 | Y-form DNA binding(GO:0000403) |
1.3 | 11.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.2 | 3.7 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
1.2 | 2.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.2 | 17.2 | GO:0031402 | sodium ion binding(GO:0031402) |
1.2 | 6.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
1.2 | 5.9 | GO:0000146 | microfilament motor activity(GO:0000146) |
1.2 | 3.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.2 | 17.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
1.2 | 6.9 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
1.1 | 2.2 | GO:0016530 | metallochaperone activity(GO:0016530) |
1.1 | 24.3 | GO:0052713 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.1 | 3.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
1.1 | 5.5 | GO:0070728 | leucine binding(GO:0070728) |
1.1 | 9.8 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
1.1 | 2.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.1 | 5.5 | GO:1990254 | keratin filament binding(GO:1990254) |
1.1 | 3.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
1.1 | 14.1 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
1.1 | 4.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.0 | 6.3 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
1.0 | 7.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
1.0 | 3.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
1.0 | 12.2 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
1.0 | 3.0 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
1.0 | 1.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.0 | 2.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.0 | 9.8 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
1.0 | 2.9 | GO:0016015 | morphogen activity(GO:0016015) |
1.0 | 5.8 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
1.0 | 4.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.9 | 2.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.9 | 2.8 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.9 | 3.7 | GO:0034584 | piRNA binding(GO:0034584) |
0.9 | 2.7 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.9 | 3.6 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.9 | 7.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.9 | 0.9 | GO:0003896 | DNA primase activity(GO:0003896) |
0.9 | 4.4 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.9 | 20.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.9 | 3.5 | GO:0009374 | biotin binding(GO:0009374) |
0.9 | 2.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.9 | 4.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.8 | 1.7 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.8 | 1.7 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.8 | 1.7 | GO:0097016 | L27 domain binding(GO:0097016) |
0.8 | 3.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.8 | 2.5 | GO:2001070 | starch binding(GO:2001070) |
0.8 | 5.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.8 | 2.5 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.8 | 1.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.8 | 4.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.8 | 3.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.8 | 8.0 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.8 | 21.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.8 | 9.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.8 | 10.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.8 | 6.8 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.7 | 3.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.7 | 3.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.7 | 8.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.7 | 4.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.7 | 6.6 | GO:0039706 | co-receptor binding(GO:0039706) |
0.7 | 2.9 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.7 | 5.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.7 | 2.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.7 | 10.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.7 | 17.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.7 | 2.9 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.7 | 7.8 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.7 | 1.4 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.7 | 11.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.7 | 27.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.7 | 1.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.7 | 20.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.7 | 6.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.7 | 5.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.7 | 12.6 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.7 | 13.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.7 | 3.3 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.6 | 6.4 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.6 | 1.9 | GO:0070052 | collagen V binding(GO:0070052) |
0.6 | 2.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.6 | 3.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.6 | 8.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.6 | 1.9 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.6 | 9.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.6 | 12.9 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.6 | 1.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.6 | 3.6 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.6 | 6.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.6 | 5.4 | GO:0008266 | poly-pyrimidine tract binding(GO:0008187) poly(U) RNA binding(GO:0008266) |
0.6 | 2.4 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.6 | 1.8 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.6 | 54.4 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.6 | 3.5 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.6 | 2.9 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.6 | 0.6 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.6 | 1.7 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.6 | 2.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.6 | 6.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.6 | 7.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.6 | 10.1 | GO:0005112 | Notch binding(GO:0005112) |
0.6 | 1.7 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.6 | 4.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.5 | 22.3 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.5 | 1.6 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.5 | 9.6 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.5 | 2.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.5 | 1.6 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.5 | 12.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.5 | 2.6 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.5 | 1.5 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.5 | 10.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.5 | 9.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.5 | 1.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.5 | 3.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.5 | 6.7 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.5 | 2.9 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.5 | 2.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.5 | 2.3 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.5 | 0.9 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.5 | 1.4 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.5 | 1.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.4 | 7.2 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.4 | 3.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.4 | 0.9 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.4 | 1.7 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.4 | 1.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.4 | 1.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.4 | 1.3 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.4 | 1.3 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.4 | 1.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.4 | 5.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.4 | 0.4 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.4 | 3.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.4 | 1.6 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.4 | 2.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.4 | 1.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.4 | 5.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.4 | 3.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.4 | 1.6 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.4 | 0.8 | GO:0030519 | snoRNP binding(GO:0030519) |
0.4 | 3.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.4 | 3.0 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.4 | 4.9 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.4 | 0.4 | GO:0008193 | RNA guanylyltransferase activity(GO:0008192) tRNA guanylyltransferase activity(GO:0008193) |
0.4 | 1.5 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 1.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.4 | 1.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.4 | 1.8 | GO:0016151 | nickel cation binding(GO:0016151) |
0.4 | 9.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.4 | 3.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.4 | 1.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.4 | 1.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 1.4 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.3 | 1.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 1.0 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.3 | 1.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 0.7 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 0.7 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.3 | 5.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 1.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 0.9 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.3 | 1.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.3 | 1.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.3 | 6.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.3 | 0.3 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.3 | 2.9 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.3 | 1.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.3 | 0.9 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.3 | 1.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 6.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.3 | 11.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.3 | 0.8 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.3 | 1.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.3 | 0.8 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.3 | 5.1 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.3 | 1.1 | GO:0038100 | nodal binding(GO:0038100) |
0.3 | 8.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.3 | 12.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.3 | 0.8 | GO:0052623 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.3 | 0.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.3 | 1.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.3 | 1.0 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 6.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 0.7 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 5.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 1.2 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.2 | 0.2 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.2 | 0.7 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 0.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 2.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 0.9 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 3.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 0.5 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.2 | 0.7 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 0.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 0.4 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.2 | 0.2 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.2 | 1.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 0.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 3.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 0.8 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 1.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 0.8 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 1.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 0.6 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.2 | 2.3 | GO:0031404 | chloride ion binding(GO:0031404) |
0.2 | 0.8 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 6.5 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.2 | 1.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 2.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 0.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 1.6 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 1.0 | GO:0070990 | snRNP binding(GO:0070990) |
0.2 | 0.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 0.2 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.2 | 2.5 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 1.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.2 | 0.7 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.2 | 0.7 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.2 | 1.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 1.6 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.2 | 0.5 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.2 | 0.7 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 1.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 0.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.2 | 1.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 0.6 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.2 | 2.2 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.2 | 1.7 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.2 | 0.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 2.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.3 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
0.2 | 0.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 0.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.1 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 1.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.4 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.4 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.4 | GO:0034903 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 0.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 1.7 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 11.8 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 3.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 2.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 1.5 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 4.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.2 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 42.7 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.3 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.3 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.4 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.1 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.1 | 0.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 1.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.1 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 2.9 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.7 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 1.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 0.2 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 2.0 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.7 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.3 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.2 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 0.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.5 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.0 | GO:0035877 | death effector domain binding(GO:0035877) |
0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 1.2 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.3 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.3 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.0 | 0.3 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 1.7 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 0.4 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.0 | 0.5 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.0 | 0.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 11.0 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.1 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 1.4 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.0 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 2.1 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 0.0 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.0 | 0.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 66.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.9 | 3.8 | PID S1P S1P3 PATHWAY | S1P3 pathway |
1.4 | 27.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
1.4 | 1.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.2 | 3.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
1.0 | 2.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
1.0 | 16.9 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.9 | 5.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.7 | 1.5 | PID REELIN PATHWAY | Reelin signaling pathway |
0.7 | 13.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.7 | 21.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.7 | 17.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.7 | 9.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.7 | 9.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.6 | 17.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.6 | 13.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.6 | 9.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.6 | 12.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 16.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.5 | 4.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.5 | 2.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.5 | 1.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.5 | 8.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.5 | 7.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 4.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 9.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.4 | 1.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.4 | 4.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 1.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 14.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 2.4 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 18.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.3 | 4.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 6.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 0.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 3.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 2.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 0.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 11.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 6.2 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 0.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 3.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 0.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 0.7 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 4.1 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 2.1 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 16.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 26.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 2.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 1.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.4 | PID NOTCH PATHWAY | Notch signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.3 | 73.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
4.7 | 56.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
3.6 | 10.7 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
3.0 | 70.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
2.6 | 33.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
2.4 | 4.7 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
2.3 | 4.7 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
1.8 | 46.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
1.7 | 17.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
1.5 | 31.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.5 | 31.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.5 | 28.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.5 | 11.7 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.4 | 14.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
1.3 | 10.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
1.3 | 53.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.3 | 28.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
1.3 | 5.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.1 | 10.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
1.1 | 3.4 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
1.1 | 4.4 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
1.0 | 11.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
1.0 | 13.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.0 | 8.7 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.9 | 7.3 | REACTOME OPSINS | Genes involved in Opsins |
0.9 | 19.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.9 | 10.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.8 | 6.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.8 | 4.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.8 | 9.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.8 | 11.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.7 | 2.9 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.7 | 5.6 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.7 | 20.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.7 | 0.7 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.7 | 7.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.6 | 13.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.6 | 6.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.6 | 6.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.6 | 5.8 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.6 | 1.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.6 | 21.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.6 | 1.1 | REACTOME KINESINS | Genes involved in Kinesins |
0.6 | 2.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.6 | 15.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.6 | 11.7 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.5 | 7.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.5 | 11.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.5 | 0.5 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.5 | 5.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.5 | 5.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.4 | 1.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.4 | 4.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.4 | 28.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.4 | 9.5 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.4 | 4.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.4 | 5.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.4 | 6.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.4 | 3.5 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.3 | 0.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 12.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 3.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 3.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 2.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.3 | 7.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.3 | 1.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 1.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 2.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 3.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 1.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.2 | 2.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 1.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 3.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 2.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 3.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 1.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 1.6 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 5.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.3 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 0.7 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.1 | 1.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 1.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 1.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 0.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 0.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.0 | REACTOME ADAPTIVE IMMUNE SYSTEM | Genes involved in Adaptive Immune System |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |